Cite
Chang CH, Yang SS, Tsai YC, et al. Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications. Ci Ji Yi Xue Za Zhi. 2018;30(3):169-175doi: 10.4103/tcmj.tcmj_106_17.
Chang, C. H., Yang, S. S., Tsai, Y. C., Kuo, S. W., Cherng, S. C., Lu, C. C., Yen, R. F., Wu, V. C., & Hu, Y. H. (2018). Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications. Ci ji yi xue za zhi = Tzu-chi medical journal, 30(3), 169-175. https://doi.org/10.4103/tcmj.tcmj_106_17
Chang, Chia-Hui, et al. "Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications." Ci ji yi xue za zhi = Tzu-chi medical journal vol. 30,3 (2018): 169-175. doi: https://doi.org/10.4103/tcmj.tcmj_106_17
Chang CH, Yang SS, Tsai YC, Kuo SW, Cherng SC, Lu CC, Yen RF, Wu VC, Hu YH. Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications. Ci Ji Yi Xue Za Zhi. 2018 Jul-Sep;30(3):169-175. doi: 10.4103/tcmj.tcmj_106_17. PMID: 30069126; PMCID: PMC6047325.
Copy
Download .nbib